Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD99 Expression in Glioblastoma Molecular Subtypes and Role in Migration and Invasion

6 Mar 2019

Abstract excerpt

Glioblastoma (GBM) is the most aggressive type of brain tumor, with an overall survival of 17 months under the current standard of care therapy. CD99, an over-expressed transmembrane protein in several malignancies, has been considered a potential target for immunotherapy. To further understand this potentiality, we analyzed the differential expression of its two isoforms in human astrocytoma specimens, and the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Adhesion Molecules Research
Share to Drug Transport and Resistance Mechanisms
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30845661
DOI: 10.3390/ijms20051137

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD99 Expression in Glioblastoma Molecular Subtypes and Role in Migration and InvasionPMID 30845661Read ↗

Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients.Semantic proximity Read ↗

CD99 is a potential diagnostic and immunological biomarker in pan-cancerSemantic proximity Read ↗

Understanding cytoskeleton regulators in glioblastoma multiforme for therapy designSemantic proximity Read ↗

RUNX1/CD44 axis regulates the proliferation, migration, and immunotherapy of gliomas: A single-cell sequencing analysis.Semantic proximity Read ↗

Loss of CD99L2 contributed to temozolomide resistance and glioblastoma tumorigenesis based on Genome-scale CRISPR/Cas9 screeningSemantic proximity Read ↗

The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerabilitySemantic proximity Read ↗

CD13 expression affects glioma patient survival and influences key functions of human glioblastoma cell lines in vitroSemantic proximity Read ↗

Prostaglandin F2 receptor inhibitor (PTGFRN) a cell adhesion molecule, promotes cell growth and migration in glioblastomaSemantic proximity Read ↗

Identification of established and novel extracellular matrix components in glioblastoma as targets for angiogenesis and prognosisSemantic proximity Read ↗

Clinical and preclinical characterization of CD99 isoforms in acute myeloid leukemiaSemantic proximity Read ↗

The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerabilitySemantic proximity Read ↗

Epithelial-mesenchymal transition in glioblastoma progressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.